
Many people assume LDL cholesterol is simply a matter of how much fat is on the plate. Dr. Mitch Rice, a board-certified family medicine physician, says that after treating more than 10,000 patients with elevated LDL he kept seeing a different pattern: insulin resistance and excess visceral fat. That is a clinical observation, not a study, but the mechanism behind it is well described in the research on diabetic dyslipidemia. Some popular versions of this idea stretch the science, though, and several of the numbers quoted don’t hold up. This guide keeps what the evidence supports, corrects what it doesn’t, and turns the useful parts into three practical strategies. (Based on the insights of Dr. Mitch Rice)
Key Takeaways
- Insulin resistance can raise LDL particles by increasing free fatty acid flow to the liver, boosting VLDL production, and impairing apoB breakdown. It typically produces high triglycerides, low HDL and small LDL particles.
- A standard panel shows LDL-C, not particle number. Ask about apoB if you have a large waist, high triglycerides or prediabetes.
- Short walks after meals lower blood glucose (10-minute walks cut the 3-hour rise by 12% overall and 22% after dinner in type 2 diabetes). A direct effect on VLDL is unproven.
- Common corrections: the probiotic study showed about a 35% to 37% fall in visceral fat over 90 days in 15 people, not 50% in 4 weeks, and a week of short sleep cut insulin sensitivity by 11% to 20%, not 25%.
- Insulin resistance isn’t the only cause of high LDL. Saturated fat and genetics still matter, and treatment decisions depend on your overall risk.
How Insulin Resistance Can Push LDL Up
When your cells respond poorly to insulin, several things happen in the liver and fat tissue at once. Fat cells release more free fatty acids because insulin no longer holds that release in check, and those fatty acids travel to the liver. The liver responds by building and releasing more triglyceride-rich VLDL particles. At the same time, insulin resistance impairs the breakdown of apoB, the structural protein that wraps each of these particles, so more of it is available to assemble new ones. A 2015 review in Diabetologia describes this combination of increased VLDL production and slower clearance as the core of diabetic dyslipidemia.
The result is not simply “more cholesterol.” High triglycerides prompt a transfer protein called CETP to swap triglycerides into LDL and out of HDL, which leaves small, triglyceride-rich LDL particles and lowers HDL. Dr. Rice credits an enzyme called hepatic lipase for creating small, dense LDL, but the review attributes it mainly to CETP and notes that insulin’s effect on hepatic lipase is controversial. The practical picture is the same: insulin resistance tends to produce high triglycerides, low HDL and a crowd of small LDL particles.
What a Standard Cholesterol Panel Doesn’t Show
A standard lipid panel reports LDL-C, the amount of cholesterol carried inside LDL particles. It does not tell you how many particles are carrying it. Two people can share the same LDL-C and still have different particle counts, and many, though not all, studies find that particle number, measured by apoB, tracks cardiovascular risk more closely. In one Framingham Offspring analysis described by apoB researcher Allan Sniderman, people in the bottom and top apoB thirds had almost identical LDL-C (134 and 136 mg/dL) but apoB averaging 86.7 versus 116 mg/dL, and the high-apoB group had more events. That is one expert’s selection of the evidence, and other studies have found apoB and LDL-C perform similarly, so treat it as a strong argument and not a settled rule.
Dr. Rice also says small, dense LDL is “significantly more atherogenic.” There is a caveat: a review of LDL particle number notes that small particle size mostly reflects a larger number of particles, and that size generally doesn’t predict heart disease independently once particle number is accounted for. What matters most is how many atherogenic particles you carry.
Strategy 1: Reduce Visceral Fat
Visceral fat sits around the organs and sends free fatty acids almost directly to the liver, which is why two people of the same weight can have very different metabolic profiles. A 2019 position statement in The Lancet Diabetes & Endocrinology concluded that excess visceral and ectopic fat play a major role in cardiovascular disease and type 2 diabetes, and that BMI doesn’t capture them. Waist circumference is a better everyday marker.
Walk After Meals
Dr. Rice recommends a 10-minute walk after most meals. The best evidence is for blood sugar: in a randomized crossover study of 41 adults with type 2 diabetes, 10-minute walks after meals lowered the 3-hour glucose rise by 12% overall and 22% after dinner. A 2022 meta-analysis also found that breaking up sitting with light walking lowered glucose and insulin. He goes further and says walking reduces the liver’s VLDL production, but we found no trial that shows this, so treat it as a plausible idea and not a proven effect. The glucose benefit alone is reason enough to walk.
Try Squats as an Alternative
Dr. Rice suggests 10 to 30 bodyweight squats after eating if walking isn’t possible. We fou

